Dimensional新兴市场(不含中国)核心股票主动型ETF DEXC 深 沪
等待开盘 07-07 09:30:00 美东时间
81.04
+2.170
+2.75%
华盛通- 最 高81.4699
- 今 开80.95
- 成交量 1.15万股
- 最 低 80.95
- 昨 收 78.87
- 总市值 3.36亿
- 52周最高 86.2881
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 52.41
- 委 比 0.00%
- 总股本 415.00万
- 历史最高 86.2881
- 量 比 0.37
- 振 幅 0.66%
- 历史最低 41.0908
- 每 手 1
- 风险率 9.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Dexcom Says Use Of Dexcom G7 Leads To Improvement In Glucose Control In People With Type 2 Diabetes Not Using Insulin Versus Routine Care Control Group
BRIEF-Dexcom Says Use Of Dexcom G7 Leads To Improvement In Glucose Control In People With Type 2 Diabetes Not Using Insulin Versus Routine Care Control Group June 6 (Reuters) - Dexcom Inc DXCM.O : DEXCOM: USE OF DEXCOM G7 LEADS TO IMPROVEMENT IN GLUCOSE CONTROL IN PEOPLE WITH TYPE 2 DIABETES NOT USI
06-07 02:45
BRIEF-Dexcom Uncovers Theft Of Scrapped Product, Notifies Potentially Impacted Users
BRIEF-Dexcom Uncovers Theft Of Scrapped Product, Notifies Potentially Impacted Users May 26 (Reuters) - Dexcom Inc DXCM.O : DEXCOM UNCOVERS THEFT OF SCRAPPED PRODUCT, NOTIFIES POTENTIALLY IMPACTED USERS DEXCOM INC - IDENTIFIES STOLEN LOTS OF G7 SENSORS SOLD BY THIRD PARTIES DEXCOM INC - SALES OF STO
05-26 21:46
Infosys Pushes AI Adoption With Harness Partnership For Faster Results
Infosys partners with Harness to boost AI-driven software delivery, improve productivity and accelerate enterprise transformation.
04-08 00:22
Infosys Expands AI Push with Two Strategic Acquisitions
Infosys boosts AI capabilities with dual acquisitions, targeting growth in healthcare and insurance digital transformation markets.
03-26 19:23
Infosys Launches AI-Powered Formula E Race Centre To Deepen Fan Engagement
Infosys shares rise on Friday as investors cheer its AI-powered Formula E launch and recent Intel partnership despite broader market weakness.
03-20 23:01
BRIEF-FDA Says Dexcom Issues Correction For Dexcom G6 And G6 Pro Software
Dec 29 (Reuters) - FDA: FDA- DEXCOM ISSUES CORRECTION FOR DEXCOM G6 AND G6 PRO SOFTWARE
2025-12-30 02:47
BRIEF-Syremis Therapeutics Launches With $165M for Mental‑Health Medicines
Dec 18 (Reuters) - SYREMIS THERAPEUTICS LAUNCHES WITH $165M TO DEVELOP BEST-IN-CLASS MEDICINES FOR MENTAL HEALTH CONDITIONS SYREMIS THERAPEUTICS: SERIES A CO-LED BY DEXCEL PHARMA & THIRD ROCK VENTURES...
2025-12-18 21:43
BRIEF-Listening To Healthcare Professionals Dexcom Launches New Education Offering, Dexcom Academy
Dec 4 (Reuters) - Dexcom Inc DXCM.O: LISTENING TO HEALTHCARE PROFESSIONALS: DEXCOM LAUNCHES NEW EDUCATION OFFERING, DEXCOM ACADEMY Source text: ID:nBw6DWkJha Further company coverage: DXCM.O ((Reuters...
2025-12-04 21:05
BRIEF-Dexcom Smart Basal Receives FDA Clearance Becoming The First And Only Cgm-Integrated Basal Insulin Dosing Optimizer For Type 2 Diabetes
Dexcom Inc DXCM.O: DEXCOM SMART BASAL RECEIVES FDA CLEARANCE BECOMING THE FIRST AND ONLY CGM-INTEGRATED BASAL INSULIN DOSING OPTIMIZER FOR TYPE 2 DIABETES Source text: ID:nBwFg6NPa Further company cov...
2025-11-19 21:53
BRIEF-Dexcom Inc - CEO Kevin R. Sayer Takes Temporary Medical Leave - SEC Filing
Sept 16 (Reuters) - Dexcom Inc DXCM.O: DEXCOM INC - CEO KEVIN R. SAYER TAKES TEMPORARY MEDICAL LEAVE - SEC FILING DEXCOM INC - JACOB S. LEACH APPOINTED INTERIM CEO OF DEXCOM - SEC FILING DEXCOM INC - ...
2025-09-16 20:59
